US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Aptevo Therapeutics

4.27

-0.2400-5.32%

Post-market: 4.270.0016+0.04%19:58 EDT

Volume:82.75K

Turnover:362.06K

Market Cap:5.05M

PE:-0.01

High:4.55

Open:4.50

Low:4.14

Close:4.51

52wk High:1,299.60

52wk Low:3.95

Shares:1.18M

Float Shares:1.18M

Volume Ratio:2.72

T/O Rate:7.01%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-351.3949

EPS(LYR):-1,747.6642

ROE:-242.74%

ROA:-79.19%

PB:0.29

PE(LYR):0.00

Loading ...

Overview Company News Filings

BRIEF-Aptevo Therapeutics On Jan 8, Enters Equity Purchase Agreement With Ya Ii Pn, Ltd

Aptevo Therapeutics Inc - on Jan 8, Enters Equity Purchase Agreement With Ya Ii Pn, Ltd. - SEC Filing

THOMSON REUTERS

Aptevo Therapeutics Inc - Can Issue up to $60 Mln of Common Stock - SEC Filing

THOMSON REUTERS

Aptevo Therapeutics Secures $60 Million Equity Line of Credit from Yorkville Advisors

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

Top Midday Decliners

MT Newswires Live

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

Aptevo Therapeutics Reports Strong Remission Rates and Safety for Mipletamig in Frontline AML Trial

Aptevo Therapeutics Director Grady Grant III Acquires Common Shares

Aptevo Therapeutics Unveils Preclinical Data for Trispecific Antibody APVO451 in Solid Tumors

Aptevo Therapeutics management to meet virtually with Roth Capital

Aptevo Therapeutics reports Q3 EPS (23c) vs. ($357.86) last year

Aptevo Therapeutics Q3 EPS $(2.23) Misses $(2.09) Estimate

Aptevo Therapeutics reports third-quarter net loss of $7.5 million

Aptevo Therapeutics Q3 Operating Income USD -7.61 Million

THOMSON REUTERS

Aptevo Therapeutics Q3 EPS USD -2.23

THOMSON REUTERS

Aptevo Therapeutics Inc expected to post a loss of $2.09 a share - Earnings Preview

Aptevo Therapeutics announces interim results for mipletamig in frontline AML from ongoing RAINIER clinical trial

Aptevo Therapeutics Files Initial Beneficial Ownership Statement for Bank of America Corp

Aptevo Therapeutics files to sell 6.9M shares of common stock for holders

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/APVO/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APVO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APVO\",,,,,undefined,":{"symbol":"APVO","market":"US","secType":"STK","nameCN":"Aptevo Therapeutics","latestPrice":4.27,"timestamp":1774641600000,"preClose":4.51,"halted":0,"volume":82746,"hourTrading":{"tag":"盘后","latestPrice":4.2716,"preClose":4.27,"latestTime":"19:58 EDT","volume":497,"amount":2133.7389,"timestamp":1774655939846,"change":0.0016,"changeRate":0.000375,"amplitude":0.000375},"delay":0,"changeRate":-0.053215077605321556,"floatShares":1181000,"shares":1181725,"eps":-351.3949,"marketStatus":"Market Closed","change":-0.24,"latestTime":"03-27 16:00:00 EDT","open":4.5,"high":4.55,"low":4.14,"amount":362056.40556299995,"amplitude":0.090909,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-351.3949,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":4.51,"preHourTrading":{"tag":"盘前","latestPrice":4.42,"preClose":4.51,"latestTime":"09:29 EDT","volume":5309,"amount":23944.736743999998,"timestamp":1774618157581,"change":-0.09,"changeRate":-0.019956,"amplitude":0.04878},"postHourTrading":{"tag":"盘后","latestPrice":4.2716,"preClose":4.27,"latestTime":"19:58 EDT","volume":497,"amount":2133.7389,"timestamp":1774655939846,"change":0.0016,"changeRate":0.000375,"amplitude":0.000375},"volumeRatio":2.723305},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APVO\",,,,,undefined,":{"symbol":"APVO","floatShares":1181000,"roa":"-79.19%","roe":"-242.74%","lyrEps":-1747.664228,"volumeRatio":2.723305,"shares":1181725,"dividePrice":0,"high":4.55,"amplitude":0.090909,"preClose":4.51,"low":4.14,"week52Low":3.95,"pbRate":"0.29","week52High":1299.6,"institutionHeld":0,"latestPrice":4.27,"eps":-351.3949,"divideRate":0,"volume":82746,"delay":0,"ttmEps":-351.3949,"open":4.5,"prevYearClose":9.43,"prevWeekClose":4.56,"prevMonthClose":7.32,"prevQuarterClose":9.43,"fiveDayClose":4.56,"twentyDayClose":7.32,"sixtyDayClose":9.39},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APVO\",params:#limit:5,,,undefined,":[{"date":"2026-03-26","symbol":"APVO","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774512000000,"name":null,"time":"Pre-Market","dateTimestamp":1774497600000,"actualEps":null},{"market":"US","date":"2025-12-30","symbol":"APVO","defaultRemindTime":1767105000000,"type":"split","dateTimestamp":1767070800000,"forFactor":18,"toFactor":1,"ratio":18},{"market":"US","date":"2025-11-06","symbol":"APVO","fiscalQuarterEnding":"2025/09","expectedEps":-2.09,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-2.23},{"market":"US","date":"2025-08-11","symbol":"APVO","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-8.4},{"market":"US","date":"2025-05-27","symbol":"APVO","defaultRemindTime":1748352600000,"type":"split","dateTimestamp":1748318400000,"forFactor":20,"toFactor":1,"ratio":20}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APVO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APVO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1758081600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APVO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APVO","date":"2026-03-27","current":-0.012152,"percent":0.563651,"low":-7.650499,"twenty":-0.89925,"median":-0.203635,"eighty":0.025461,"high":3.317157,"avg":-0.409959,"sd":1.667488,"marketCap":4500213},"quantilePoints":[{"date":"2021-04-01","current":-7.096515,"twenty":-1.036961,"median":-0.710664,"eighty":-0.291055,"marketCap":125963136},{"date":"2021-04-09","current":-6.429728,"twenty":-1.044836,"median":-0.712614,"eighty":-0.291848,"marketCap":114127674},{"date":"2021-04-16","current":-6.347006,"twenty":-1.048794,"median":-0.713774,"eighty":-0.295853,"marketCap":112659365},{"date":"2021-04-23","current":-6.399647,"twenty":-1.052752,"median":-0.714717,"eighty":-0.299148,"marketCap":113593743},{"date":"2021-04-30","current":-6.69544,"twenty":-1.057219,"median":-0.717239,"eighty":-0.305441,"marketCap":118844061},{"date":"2021-05-07","current":-5.915851,"twenty":-1.06355,"median":-0.717239,"eighty":-0.30628,"marketCap":105006359},{"date":"2021-05-14","current":-3.654924,"twenty":-1.06988,"median":-0.71881,"eighty":-0.30704,"marketCap":101983342},{"date":"2021-05-21","current":-4.045612,"twenty":-1.077477,"median":-0.720566,"eighty":-0.308639,"marketCap":112884702},{"date":"2021-05-28","current":-4.16521,"twenty":-1.085074,"median":-0.720979,"eighty":-0.311038,"marketCap":116221854},{"date":"2021-06-04","current":-4.18594,"twenty":-1.089467,"median":-0.720979,"eighty":-0.315516,"marketCap":116800293},{"date":"2021-06-11","current":-4.119763,"twenty":-1.099941,"median":-0.722931,"eighty":-0.317754,"marketCap":114953736},{"date":"2021-06-18","current":-4.362946,"twenty":-1.110102,"median":-0.724861,"eighty":-0.31884,"marketCap":121739277},{"date":"2021-06-25","current":-3.973853,"twenty":-1.122632,"median":-0.725492,"eighty":-0.320315,"marketCap":110882412},{"date":"2021-07-02","current":-3.415727,"twenty":-1.134735,"median":-0.726043,"eighty":-0.329595,"marketCap":95309039},{"date":"2021-07-09","current":-3.511406,"twenty":-1.144489,"median":-0.727014,"eighty":-0.331857,"marketCap":97978760},{"date":"2021-07-16","current":-3.020256,"twenty":-1.160845,"median":-0.727634,"eighty":-0.333284,"marketCap":84274192},{"date":"2021-07-23","current":-3.288953,"twenty":-1.173703,"median":-0.728025,"eighty":-0.336476,"marketCap":91771659},{"date":"2021-07-30","current":-2.993147,"twenty":-1.188744,"median":-0.728605,"eighty":-0.340524,"marketCap":83517771},{"date":"2021-08-06","current":-3.004309,"twenty":-1.195229,"median":-0.728948,"eighty":-0.342222,"marketCap":83829239},{"date":"2021-08-13","current":-2.865729,"twenty":-1.19844,"median":-0.728948,"eighty":-0.342222,"marketCap":83197847},{"date":"2021-08-20","current":-2.889329,"twenty":-1.199291,"median":-0.728948,"eighty":-0.342222,"marketCap":83883005},{"date":"2021-08-27","current":-2.963501,"twenty":-1.209157,"median":-0.729291,"eighty":-0.342703,"marketCap":86036361},{"date":"2021-09-03","current":-3.059587,"twenty":-1.225828,"median":-0.729291,"eighty":-0.342703,"marketCap":88825936},{"date":"2021-09-10","current":-2.887643,"twenty":-1.246922,"median":-0.729291,"eighty":-0.342703,"marketCap":83834065},{"date":"2021-09-17","current":-2.909558,"twenty":-1.295574,"median":-0.729291,"eighty":-0.342703,"marketCap":84470284},{"date":"2021-09-24","current":-2.823586,"twenty":-1.309523,"median":-0.729291,"eighty":-0.342703,"marketCap":81974349},{"date":"2021-10-01","current":-2.639842,"twenty":-1.31973,"median":-0.729291,"eighty":-0.342703,"marketCap":76639899},{"date":"2021-10-08","current":-2.444298,"twenty":-1.342525,"median":-0.729291,"eighty":-0.342703,"marketCap":70962869},{"date":"2021-10-15","current":-2.526899,"twenty":-1.370424,"median":-0.729291,"eighty":-0.342703,"marketCap":73360925},{"date":"2021-10-22","current":-2.402155,"twenty":-1.429717,"median":-0.729291,"eighty":-0.342703,"marketCap":69739371},{"date":"2021-10-29","current":-2.569042,"twenty":-1.507874,"median":-0.729291,"eighty":-0.342703,"marketCap":74584422},{"date":"2021-11-05","current":-2.793243,"twenty":-2.429127,"median":-0.729291,"eighty":-0.342703,"marketCap":81093430},{"date":"2021-11-12","current":-1.949966,"twenty":-2.43823,"median":-0.729291,"eighty":-0.342703,"marketCap":57013115},{"date":"2021-11-19","current":-1.222917,"twenty":-2.43823,"median":-0.729291,"eighty":-0.342703,"marketCap":35755648},{"date":"2021-11-26","current":-2.189524,"twenty":-2.441939,"median":-0.729291,"eighty":-0.342703,"marketCap":64017304},{"date":"2021-12-03","current":-1.177686,"twenty":-2.441939,"median":-0.729291,"eighty":-0.342703,"marketCap":34433179},{"date":"2021-12-10","current":-1.301653,"twenty":-2.441939,"median":-0.729291,"eighty":-0.342703,"marketCap":38057724},{"date":"2021-12-17","current":-1.360286,"twenty":-2.441939,"median":-0.729433,"eighty":-0.342703,"marketCap":39772036},{"date":"2021-12-23","current":-1.318405,"twenty":-2.441939,"median":-0.729433,"eighty":-0.342703,"marketCap":38547527},{"date":"2021-12-31","current":-1.318405,"twenty":-2.441939,"median":-0.729433,"eighty":-0.342703,"marketCap":38547527},{"date":"2022-01-07","current":-1.237994,"twenty":-2.441264,"median":-0.729433,"eighty":-0.343184,"marketCap":36196471},{"date":"2022-01-14","current":-1.209565,"twenty":-2.441264,"median":-0.729433,"eighty":-0.343184,"marketCap":35365274},{"date":"2022-01-21","current":-0.98671,"twenty":-2.441264,"median":-0.729433,"eighty":-0.343184,"marketCap":28849420},{"date":"2022-01-28","current":-0.909649,"twenty":-2.44059,"median":-0.729433,"eighty":-0.343666,"marketCap":26596324},{"date":"2022-02-04","current":-0.934778,"twenty":-2.44059,"median":-0.729433,"eighty":-0.343666,"marketCap":27331029},{"date":"2022-02-11","current":-0.985035,"twenty":-2.439915,"median":-0.729433,"eighty":-0.344147,"marketCap":28800439},{"date":"2022-02-18","current":-0.967608,"twenty":-2.439915,"median":-0.729433,"eighty":-0.344147,"marketCap":28290911},{"date":"2022-02-25","current":-0.974458,"twenty":-2.439915,"median":-0.729433,"eighty":-0.344147,"marketCap":28491201},{"date":"2022-03-04","current":-0.907667,"twenty":-2.439915,"median":-0.729433,"eighty":-0.344147,"marketCap":26538377},{"date":"2022-03-11","current":-0.813475,"twenty":-2.439915,"median":-0.730884,"eighty":-0.344147,"marketCap":23784394},{"date":"2022-03-18","current":-0.869991,"twenty":-2.439915,"median":-0.731099,"eighty":-0.344147,"marketCap":25436784},{"date":"2022-03-25","current":-1.068066,"twenty":-2.439915,"median":-0.731664,"eighty":-0.344147,"marketCap":30393952},{"date":"2022-04-01","current":-1.108536,"twenty":-2.439915,"median":-0.732068,"eighty":-0.344147,"marketCap":31545618},{"date":"2022-04-08","current":-0.948414,"twenty":-2.439915,"median":-0.733014,"eighty":-0.344147,"marketCap":26989028},{"date":"2022-04-14","current":-0.837561,"twenty":-2.439915,"median":-0.735904,"eighty":-0.344147,"marketCap":23834467},{"date":"2022-04-22","current":-0.823484,"twenty":-2.439915,"median":-0.738671,"eighty":-0.344147,"marketCap":23433887},{"date":"2022-04-29","current":-0.749582,"twenty":-2.439915,"median":-0.739917,"eighty":-0.344147,"marketCap":21330846},{"date":"2022-05-06","current":-0.710871,"twenty":-2.439915,"median":-0.740753,"eighty":-0.344147,"marketCap":20229253},{"date":"2022-05-13","current":-0.797056,"twenty":-2.439915,"median":-0.741669,"eighty":-0.344147,"marketCap":23033313},{"date":"2022-05-20","current":-0.788392,"twenty":-2.439915,"median":-0.744513,"eighty":-0.344147,"marketCap":22782951},{"date":"2022-05-27","current":-0.845572,"twenty":-2.439915,"median":-0.74549,"eighty":-0.344147,"marketCap":24435340},{"date":"2022-06-03","current":-0.864632,"twenty":-2.439915,"median":-0.745907,"eighty":-0.344147,"marketCap":24986137},{"date":"2022-06-10","current":-0.689626,"twenty":-2.439915,"median":-0.748131,"eighty":-0.344147,"marketCap":19928823},{"date":"2022-06-17","current":-0.60299,"twenty":-2.439915,"median":-0.747837,"eighty":-0.344147,"marketCap":17425202},{"date":"2022-06-24","current":-0.672299,"twenty":-2.44059,"median":-0.745751,"eighty":-0.343666,"marketCap":19428098},{"date":"2022-07-01","current":-0.620317,"twenty":-2.44059,"median":-0.745306,"eighty":-0.343666,"marketCap":17925926},{"date":"2022-07-08","current":-0.722548,"twenty":-2.44059,"median":-0.745306,"eighty":-0.343666,"marketCap":20880199},{"date":"2022-07-15","current":-0.67923,"twenty":-2.44059,"median":-0.745306,"eighty":-0.343666,"marketCap":19628388},{"date":"2022-07-22","current":-0.696557,"twenty":-2.44059,"median":-0.745673,"eighty":-0.343666,"marketCap":20129112},{"date":"2022-07-29","current":-0.682695,"twenty":-2.44059,"median":-0.745673,"eighty":-0.343666,"marketCap":19728533},{"date":"2022-08-05","current":-0.743341,"twenty":-2.44059,"median":-0.745673,"eighty":-0.343666,"marketCap":21481068},{"date":"2022-08-12","current":3.1943,"twenty":-2.44059,"median":-0.746063,"eighty":-0.336476,"marketCap":22500646},{"date":"2022-08-19","current":2.478834,"twenty":-2.44059,"median":-0.746063,"eighty":-0.318638,"marketCap":17460908},{"date":"2022-08-26","current":2.616146,"twenty":-2.44059,"median":-0.746063,"eighty":-0.306736,"marketCap":18428131},{"date":"2022-09-02","current":2.579939,"twenty":-2.44059,"median":-0.746063,"eighty":-0.291531,"marketCap":18173090},{"date":"2022-09-09","current":2.764298,"twenty":-2.44059,"median":-0.745751,"eighty":-0.272385,"marketCap":19471713},{"date":"2022-09-16","current":2.587238,"twenty":-2.44059,"median":-0.745751,"eighty":-0.261309,"marketCap":18224505},{"date":"2022-09-23","current":2.2548,"twenty":-2.44059,"median":-0.745751,"eighty":-0.238037,"marketCap":15882809},{"date":"2022-09-30","current":2.196984,"twenty":-2.44059,"median":-0.744541,"eighty":2.2548,"marketCap":15475557},{"date":"2022-10-07","current":2.124715,"twenty":-2.44059,"median":-0.743341,"eighty":2.260582,"marketCap":14966493},{"date":"2022-10-14","current":2.045219,"twenty":-2.44059,"median":-0.739917,"eighty":2.260582,"marketCap":14406522},{"date":"2022-10-21","current":2.059673,"twenty":-2.44059,"median":-0.737228,"eighty":2.260582,"marketCap":14508335},{"date":"2022-10-28","current":2.16085,"twenty":-2.44059,"median":-0.733054,"eighty":2.260582,"marketCap":15221025},{"date":"2022-11-04","current":2.074127,"twenty":-2.44059,"median":-0.730668,"eighty":2.260582,"marketCap":14610148},{"date":"2022-11-11","current":2.507275,"twenty":-2.44059,"median":-0.728605,"eighty":2.298162,"marketCap":16039037},{"date":"2022-11-18","current":2.483396,"twenty":-2.44059,"median":-0.728605,"eighty":2.476795,"marketCap":15886284},{"date":"2022-11-25","current":2.316244,"twenty":-2.44059,"median":-0.728605,"eighty":2.476795,"marketCap":14817015},{"date":"2022-12-02","current":2.467556,"twenty":-2.44059,"median":-0.728605,"eighty":2.478834,"marketCap":15784958},{"date":"2022-12-09","current":2.764529,"twenty":-2.44059,"median":-0.728025,"eighty":2.519025,"marketCap":17684693},{"date":"2022-12-16","current":1.719274,"twenty":-2.44059,"median":-0.727014,"eighty":2.542431,"marketCap":10998197},{"date":"2022-12-23","current":1.647638,"twenty":-2.44059,"median":-0.722548,"eighty":2.542431,"marketCap":10539939},{"date":"2022-12-30","current":1.846628,"twenty":-2.44059,"median":-0.719816,"eighty":2.542431,"marketCap":11812878},{"date":"2023-01-06","current":1.735193,"twenty":-2.44059,"median":-0.719816,"eighty":2.483396,"marketCap":11100032},{"date":"2023-01-13","current":1.790911,"twenty":-2.44059,"median":-0.719816,"eighty":2.467509,"marketCap":11456455},{"date":"2023-01-20","current":1.910305,"twenty":-2.44059,"median":-0.719816,"eighty":2.407217,"marketCap":12220219},{"date":"2023-01-27","current":1.902345,"twenty":-2.44059,"median":-0.719816,"eighty":2.306693,"marketCap":12169301},{"date":"2023-02-03","current":1.703355,"twenty":-2.44059,"median":-0.719816,"eighty":2.257091,"marketCap":10896362},{"date":"2023-02-10","current":1.679476,"twenty":-2.44059,"median":-0.719816,"eighty":2.192648,"marketCap":10743609},{"date":"2023-02-17","current":1.587383,"twenty":-2.44059,"median":-0.719816,"eighty":2.166632,"marketCap":10154492},{"date":"2023-02-24","current":1.59988,"twenty":-2.44059,"median":-0.719816,"eighty":2.134833,"marketCap":10234433},{"date":"2023-03-03","current":1.711315,"twenty":-2.44059,"median":-0.719816,"eighty":2.103034,"marketCap":10947279},{"date":"2023-03-10","current":1.480486,"twenty":-2.44059,"median":-0.719816,"eighty":2.062564,"marketCap":9470669},{"date":"2023-03-17","current":1.40885,"twenty":-2.44059,"median":-0.719816,"eighty":2.025349,"marketCap":9012411},{"date":"2023-03-24","current":1.472526,"twenty":-2.44059,"median":-0.719816,"eighty":1.93461,"marketCap":9419752},{"date":"2023-03-31","current":1.639331,"twenty":-2.439915,"median":-0.71945,"eighty":1.902345,"marketCap":13158908},{"date":"2023-04-06","current":1.474189,"twenty":-2.439915,"median":-0.71945,"eighty":1.846628,"marketCap":11833318},{"date":"2023-04-14","current":1.704572,"twenty":-2.44059,"median":-0.719816,"eighty":1.817973,"marketCap":13682600},{"date":"2023-04-21","current":1.650459,"twenty":-2.44059,"median":-0.719816,"eighty":1.790911,"marketCap":13248231},{"date":"2023-04-28","current":1.777625,"twenty":-2.44059,"median":-0.719816,"eighty":1.741561,"marketCap":14268997},{"date":"2023-05-05","current":1.56027,"twenty":-2.44059,"median":-0.719816,"eighty":1.719274,"marketCap":12524284},{"date":"2023-05-12","current":1.524194,"twenty":-2.44059,"median":-0.719816,"eighty":1.711315,"marketCap":12234705},{"date":"2023-05-19","current":0.661443,"twenty":-2.44059,"median":-0.719816,"eighty":1.695553,"marketCap":12234705},{"date":"2023-05-26","current":0.642423,"twenty":-2.44059,"median":-0.719816,"eighty":1.682299,"marketCap":11882897},{"date":"2023-06-02","current":0.618775,"twenty":-2.44059,"median":-0.719816,"eighty":1.671516,"marketCap":11445489},{"date":"2023-06-09","current":0.63454,"twenty":-2.44059,"median":-0.719816,"eighty":1.655597,"marketCap":11737094},{"date":"2023-06-16","current":0.630599,"twenty":-2.44059,"median":-0.719816,"eighty":1.642208,"marketCap":11664193},{"date":"2023-06-23","current":0.563598,"twenty":-2.441264,"median":-0.720122,"eighty":1.63214,"marketCap":10424873},{"date":"2023-06-30","current":0.571481,"twenty":-2.441939,"median":-0.720428,"eighty":1.615799,"marketCap":10570675},{"date":"2023-07-07","current":0.591379,"twenty":-2.441939,"median":-0.720428,"eighty":1.599173,"marketCap":10938742},{"date":"2023-07-14","current":0.636199,"twenty":-2.441939,"median":-0.720428,"eighty":1.586653,"marketCap":11767766},{"date":"2023-07-21","current":0.428256,"twenty":-2.441939,"median":-0.720428,"eighty":1.558393,"marketCap":7921442},{"date":"2023-07-28","current":0.424177,"twenty":-2.441939,"median":-0.720428,"eighty":1.502919,"marketCap":7846000},{"date":"2023-08-04","current":0.244717,"twenty":-2.441939,"median":-0.720428,"eighty":1.479227,"marketCap":4526538},{"date":"2023-08-11","current":-0.252576,"twenty":-2.441939,"median":-0.720428,"eighty":1.43432,"marketCap":4410226},{"date":"2023-08-18","current":-0.276461,"twenty":-2.441939,"median":-0.720428,"eighty":0.723408,"marketCap":4827284},{"date":"2023-08-25","current":-0.254418,"twenty":-2.441939,"median":-0.720428,"eighty":0.661992,"marketCap":4442392},{"date":"2023-09-01","current":-0.290386,"twenty":-2.441939,"median":-0.720428,"eighty":0.646249,"marketCap":5070435},{"date":"2023-09-08","current":-0.263988,"twenty":-2.441939,"median":-0.720428,"eighty":0.635867,"marketCap":4609486},{"date":"2023-09-15","current":-0.257586,"twenty":-2.441939,"median":-0.720428,"eighty":0.630506,"marketCap":4497706},{"date":"2023-09-22","current":-0.22109,"twenty":-2.441939,"median":-0.720428,"eighty":0.622717,"marketCap":3860444},{"date":"2023-09-29","current":-0.20822,"twenty":-2.441939,"median":-0.720428,"eighty":0.609249,"marketCap":3635732},{"date":"2023-10-06","current":-0.20921,"twenty":-2.441939,"median":-0.720428,"eighty":0.582476,"marketCap":3653017},{"date":"2023-10-13","current":-0.250788,"twenty":-2.441939,"median":-0.720428,"eighty":0.560099,"marketCap":4379012},{"date":"2023-10-20","current":-0.227029,"twenty":-2.441939,"median":-0.720428,"eighty":0.442123,"marketCap":3964158},{"date":"2023-10-27","current":-0.213299,"twenty":-2.443287,"median":-0.721556,"eighty":0.424177,"marketCap":3724407},{"date":"2023-11-03","current":-0.177598,"twenty":-2.443287,"median":-0.721556,"eighty":0.331961,"marketCap":3101031},{"date":"2023-11-10","current":-0.153773,"twenty":-2.443287,"median":-0.721556,"eighty":0.245484,"marketCap":2685025},{"date":"2023-11-17","current":-0.129865,"twenty":-2.443287,"median":-0.71945,"eighty":-0.117527,"marketCap":2097316},{"date":"2023-11-24","current":-0.209929,"twenty":-2.443287,"median":-0.713851,"eighty":-0.117527,"marketCap":3390347},{"date":"2023-12-01","current":-0.203984,"twenty":-2.443287,"median":-0.709909,"eighty":-0.117527,"marketCap":3294336},{"date":"2023-12-08","current":-0.210201,"twenty":-2.44295,"median":-0.705221,"eighty":-0.117764,"marketCap":3394751},{"date":"2023-12-15","current":-0.191985,"twenty":-2.44295,"median":-0.698297,"eighty":-0.117764,"marketCap":3100551},{"date":"2023-12-22","current":-0.201802,"twenty":-2.44295,"median":-0.696557,"eighty":-0.117764,"marketCap":3259102},{"date":"2023-12-29","current":-0.206602,"twenty":-2.443287,"median":-0.696557,"eighty":-0.117527,"marketCap":3336616},{"date":"2024-01-05","current":-0.206134,"twenty":-2.443624,"median":-0.696557,"eighty":-0.117289,"marketCap":3329059},{"date":"2024-01-12","current":-0.185952,"twenty":-2.443624,"median":-0.693423,"eighty":-0.117289,"marketCap":3003124},{"date":"2024-01-19","current":-0.211307,"twenty":-2.443961,"median":-0.688725,"eighty":-0.117052,"marketCap":3412604},{"date":"2024-01-26","current":-0.214349,"twenty":-2.443624,"median":-0.687824,"eighty":-0.117289,"marketCap":3461738},{"date":"2024-02-02","current":-0.211583,"twenty":-2.443624,"median":-0.686966,"eighty":-0.117289,"marketCap":3417070},{"date":"2024-02-09","current":-0.203286,"twenty":-2.443624,"median":-0.683062,"eighty":-0.117289,"marketCap":3283068},{"date":"2024-02-16","current":-0.217115,"twenty":-2.443624,"median":-0.67923,"eighty":-0.117289,"marketCap":3506405},{"date":"2024-02-23","current":-0.192223,"twenty":-2.443624,"median":-0.678183,"eighty":-0.117289,"marketCap":3104397},{"date":"2024-03-01","current":-0.235093,"twenty":-2.443287,"median":-0.675863,"eighty":-0.117527,"marketCap":3796745},{"date":"2024-03-08","current":-0.202221,"twenty":-2.443287,"median":-0.67223,"eighty":-0.117527,"marketCap":3520869},{"date":"2024-03-15","current":-0.154423,"twenty":-2.443287,"median":-0.667339,"eighty":-0.117527,"marketCap":2688663},{"date":"2024-03-22","current":-0.137265,"twenty":-2.443287,"median":-0.664222,"eighty":-0.117527,"marketCap":2389923},{"date":"2024-03-28","current":-0.124396,"twenty":-2.443287,"median":-0.663546,"eighty":-0.117527,"marketCap":2165867},{"date":"2024-04-05","current":-0.1054,"twenty":-2.443624,"median":-0.659831,"eighty":-0.109812,"marketCap":1835119},{"date":"2024-04-12","current":-0.029353,"twenty":-2.443624,"median":-0.653239,"eighty":-0.047026,"marketCap":511059},{"date":"2024-04-19","current":-0.064574,"twenty":-2.443624,"median":-0.647364,"eighty":-0.041513,"marketCap":1124300},{"date":"2024-04-26","current":-0.062756,"twenty":-2.443287,"median":-0.646527,"eighty":-0.047466,"marketCap":1092647},{"date":"2024-05-03","current":-0.104286,"twenty":-2.443287,"median":-0.646527,"eighty":-0.047466,"marketCap":1815723},{"date":"2024-05-10","current":-0.055607,"twenty":-2.443287,"median":-0.644437,"eighty":-0.045105,"marketCap":1502390},{"date":"2024-05-17","current":-0.047352,"twenty":-2.443287,"median":-0.641613,"eighty":-0.040152,"marketCap":1279362},{"date":"2024-05-24","current":-0.043409,"twenty":-2.443287,"median":-0.639004,"eighty":-0.037787,"marketCap":1172828},{"date":"2024-05-31","current":-0.107614,"twenty":-2.443287,"median":-0.639004,"eighty":-0.037787,"marketCap":2907509},{"date":"2024-06-07","current":-0.119469,"twenty":-2.443287,"median":-0.635199,"eighty":-0.037787,"marketCap":3227800},{"date":"2024-06-14","current":-0.115935,"twenty":-2.443287,"median":-0.628407,"eighty":-0.037787,"marketCap":3132325},{"date":"2024-06-21","current":-0.080325,"twenty":-2.443624,"median":-0.624514,"eighty":-0.034975,"marketCap":2170227},{"date":"2024-06-28","current":-0.046217,"twenty":-2.443624,"median":-0.620317,"eighty":-0.034975,"marketCap":1248681},{"date":"2024-07-05","current":-0.101777,"twenty":-2.443624,"median":-0.616122,"eighty":-0.034975,"marketCap":2749823},{"date":"2024-07-12","current":-0.1091,"twenty":-2.443624,"median":-0.61378,"eighty":-0.034975,"marketCap":2947652},{"date":"2024-07-19","current":-0.153451,"twenty":-2.443624,"median":-0.60978,"eighty":-0.034975,"marketCap":4145931},{"date":"2024-07-26","current":-0.143304,"twenty":-2.443624,"median":-0.6023,"eighty":-0.034975,"marketCap":3871797},{"date":"2024-08-02","current":-0.145396,"twenty":-2.443624,"median":-0.597967,"eighty":-0.034975,"marketCap":3928319},{"date":"2024-08-09","current":-0.141082,"twenty":-2.443624,"median":-0.59008,"eighty":-0.034975,"marketCap":3520428},{"date":"2024-08-16","current":-0.15792,"twenty":-2.443624,"median":-0.585677,"eighty":-0.034975,"marketCap":3940581},{"date":"2024-08-23","current":-0.152182,"twenty":-2.443624,"median":-0.577168,"eighty":-0.034975,"marketCap":3797390},{"date":"2024-08-30","current":-0.13591,"twenty":-2.443624,"median":-0.575266,"eighty":-0.034975,"marketCap":3391368},{"date":"2024-09-06","current":-0.124547,"twenty":-2.443624,"median":-0.572309,"eighty":-0.034975,"marketCap":3107812},{"date":"2024-09-13","current":-0.133985,"twenty":-2.443624,"median":-0.56487,"eighty":-0.034975,"marketCap":3343324},{"date":"2024-09-20","current":-0.091626,"twenty":-2.443624,"median":-0.554636,"eighty":-0.034975,"marketCap":2286339},{"date":"2024-09-27","current":-0.096581,"twenty":-2.443624,"median":-0.551427,"eighty":-0.034975,"marketCap":2409998},{"date":"2024-10-04","current":-0.091087,"twenty":-2.443624,"median":-0.551427,"eighty":-0.034975,"marketCap":2272898},{"date":"2024-10-11","current":-0.078375,"twenty":-2.443624,"median":-0.551427,"eighty":-0.034975,"marketCap":1955687},{"date":"2024-10-18","current":-0.106924,"twenty":-2.443624,"median":-0.550303,"eighty":-0.034975,"marketCap":2668068},{"date":"2024-10-25","current":-0.132079,"twenty":-2.443624,"median":-0.537303,"eighty":-0.034975,"marketCap":3295770},{"date":"2024-11-01","current":-0.133587,"twenty":-2.443624,"median":-0.536692,"eighty":-0.034975,"marketCap":3333405},{"date":"2024-11-08","current":-0.215861,"twenty":-2.443624,"median":-0.507418,"eighty":-0.034975,"marketCap":5120441},{"date":"2024-11-15","current":-0.164666,"twenty":-2.443624,"median":-0.489951,"eighty":-0.034975,"marketCap":3906048},{"date":"2024-11-22","current":-0.240132,"twenty":-2.443624,"median":-0.476778,"eighty":-0.034975,"marketCap":5696166},{"date":"2024-11-29","current":-0.218593,"twenty":-2.443624,"median":-0.458628,"eighty":-0.034975,"marketCap":5185233},{"date":"2024-12-06","current":-0.204593,"twenty":-2.443624,"median":-0.419596,"eighty":-0.034975,"marketCap":4853162},{"date":"2024-12-13","current":-0.086267,"twenty":-2.443624,"median":-0.399792,"eighty":-0.034975,"marketCap":2046333},{"date":"2024-12-20","current":-0.093016,"twenty":-2.443624,"median":-0.385345,"eighty":-0.034975,"marketCap":2206437},{"date":"2024-12-27","current":-0.101453,"twenty":-2.443624,"median":-0.346215,"eighty":-0.034975,"marketCap":2406568},{"date":"2025-01-03","current":-0.096602,"twenty":-2.443624,"median":-0.334226,"eighty":-0.034975,"marketCap":2291493},{"date":"2025-01-10","current":-0.101031,"twenty":-2.443961,"median":-0.318538,"eighty":-0.032164,"marketCap":2396561},{"date":"2025-01-17","current":-0.094071,"twenty":-2.443961,"median":-0.30666,"eighty":-0.032164,"marketCap":2231453},{"date":"2025-01-24","current":-0.099555,"twenty":-2.443961,"median":-0.29642,"eighty":-0.032164,"marketCap":2361538},{"date":"2025-01-31","current":-0.092383,"twenty":-2.443961,"median":-0.282914,"eighty":-0.032164,"marketCap":2191427},{"date":"2025-02-07","current":-0.084368,"twenty":-2.443961,"median":-0.27524,"eighty":-0.032164,"marketCap":2001304},{"date":"2025-02-14","current":-0.201873,"twenty":-2.443961,"median":-0.270257,"eighty":-0.032164,"marketCap":4871206},{"date":"2025-02-21","current":-0.209731,"twenty":-2.443961,"median":-0.268477,"eighty":-0.032164,"marketCap":5060804},{"date":"2025-02-28","current":-0.230885,"twenty":-2.443961,"median":-0.263328,"eighty":-0.032164,"marketCap":5571259},{"date":"2025-03-07","current":-0.153521,"twenty":-2.444298,"median":-0.260028,"eighty":-0.029353,"marketCap":3704450},{"date":"2025-03-14","current":-0.145663,"twenty":-2.444298,"median":-0.255856,"eighty":-0.029353,"marketCap":3514852},{"date":"2025-03-21","current":-0.155334,"twenty":-2.444298,"median":-0.254418,"eighty":-0.029353,"marketCap":3748203},{"date":"2025-03-28","current":-0.067694,"twenty":-2.444298,"median":-0.248676,"eighty":-0.029353,"marketCap":1633458},{"date":"2025-04-04","current":-0.19903,"twenty":-2.444298,"median":-0.240132,"eighty":-0.029353,"marketCap":4802588},{"date":"2025-04-11","current":-0.134913,"twenty":-2.443961,"median":-0.229287,"eighty":-0.032164,"marketCap":3255446},{"date":"2025-04-17","current":-0.11513,"twenty":-2.443961,"median":-0.225717,"eighty":-0.032164,"marketCap":2778088},{"date":"2025-04-25","current":-0.155129,"twenty":-2.444298,"median":-0.221264,"eighty":-0.029353,"marketCap":3743260},{"date":"2025-05-02","current":-0.129886,"twenty":-2.444298,"median":-0.218498,"eighty":-0.029353,"marketCap":3134160},{"date":"2025-05-09","current":-0.088235,"twenty":-2.444298,"median":-0.217115,"eighty":-0.029353,"marketCap":2129100},{"date":"2025-05-16","current":-0.084537,"twenty":-2.444298,"median":-0.215594,"eighty":-0.029353,"marketCap":2003858},{"date":"2025-05-23","current":-0.079253,"twenty":-2.444298,"median":-0.214349,"eighty":-0.029353,"marketCap":1878617},{"date":"2025-05-30","current":-0.134196,"twenty":-2.444298,"median":-0.212966,"eighty":-0.029353,"marketCap":3180978},{"date":"2025-06-06","current":-0.13648,"twenty":-2.444298,"median":-0.211583,"eighty":-0.029353,"marketCap":3235123},{"date":"2025-06-13","current":-0.13648,"twenty":-2.444298,"median":-0.21094,"eighty":-0.029353,"marketCap":3235123},{"date":"2025-06-20","current":-0.679947,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":16117454},{"date":"2025-06-27","current":-0.504992,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":11970328},{"date":"2025-07-03","current":-0.475286,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":11266191},{"date":"2025-07-11","current":-0.470596,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":11155011},{"date":"2025-07-18","current":-0.465906,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":11043832},{"date":"2025-07-25","current":-0.501865,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":11896208},{"date":"2025-08-01","current":-0.4362,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":10339695},{"date":"2025-08-08","current":-0.334577,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":7930805},{"date":"2025-08-15","current":-0.279182,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":6707352},{"date":"2025-08-22","current":-0.283288,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":6805990},{"date":"2025-08-29","current":-0.232652,"twenty":-2.444972,"median":-0.210339,"eighty":0.025461,"marketCap":5589460},{"date":"2025-09-05","current":-0.223072,"twenty":-2.445647,"median":-0.210201,"eighty":0.080275,"marketCap":5359306},{"date":"2025-09-12","current":-0.205281,"twenty":-2.444972,"median":-0.209929,"eighty":0.025461,"marketCap":4931877},{"date":"2025-09-19","current":-0.270971,"twenty":-2.444972,"median":-0.209413,"eighty":0.025461,"marketCap":6510077},{"date":"2025-09-26","current":-0.218966,"twenty":-2.444972,"median":-0.209413,"eighty":0.025461,"marketCap":5260668},{"date":"2025-10-03","current":-0.198438,"twenty":-2.444972,"median":-0.208489,"eighty":0.025461,"marketCap":4767481},{"date":"2025-10-10","current":-0.240863,"twenty":-2.444972,"median":-0.208216,"eighty":0.025461,"marketCap":5786735},{"date":"2025-10-17","current":-0.205281,"twenty":-2.444972,"median":-0.208052,"eighty":0.025461,"marketCap":4931877},{"date":"2025-10-24","current":-0.209387,"twenty":-2.444972,"median":-0.20789,"eighty":0.025461,"marketCap":5030514},{"date":"2025-10-31","current":-0.191596,"twenty":-2.444972,"median":-0.207147,"eighty":0.025461,"marketCap":4603085},{"date":"2025-11-07","current":-0.201175,"twenty":-2.435195,"median":-0.206543,"eighty":0.025461,"marketCap":4833239},{"date":"2025-11-14","current":-0.922949,"twenty":-2.164085,"median":-0.206078,"eighty":0.025461,"marketCap":24433216},{"date":"2025-11-21","current":-0.687438,"twenty":-1.695666,"median":-0.206078,"eighty":0.025461,"marketCap":18198533},{"date":"2025-11-28","current":-0.878392,"twenty":-1.509716,"median":-0.206078,"eighty":0.025461,"marketCap":23253681},{"date":"2025-12-05","current":-0.884758,"twenty":-1.361961,"median":-0.206078,"eighty":0.025461,"marketCap":23422186},{"date":"2025-12-12","current":-0.738359,"twenty":-1.335827,"median":-0.206078,"eighty":0.025461,"marketCap":19546573},{"date":"2025-12-19","current":-0.661977,"twenty":-1.321756,"median":-0.206078,"eighty":0.025461,"marketCap":17524513},{"date":"2025-12-26","current":-0.592024,"twenty":-1.298972,"median":-0.206078,"eighty":0.025461,"marketCap":15672644},{"date":"2026-01-02","current":-0.333464,"twenty":-1.258097,"median":-0.206078,"eighty":0.025461,"marketCap":8827790},{"date":"2026-01-09","current":-0.325331,"twenty":-1.223267,"median":-0.206078,"eighty":0.025461,"marketCap":8612478},{"date":"2026-01-16","current":-0.340362,"twenty":-1.194783,"median":-0.206078,"eighty":0.025461,"marketCap":9010404},{"date":"2026-01-23","current":-0.336593,"twenty":-1.097033,"median":-0.206078,"eighty":0.025461,"marketCap":8910621},{"date":"2026-01-30","current":-0.278547,"twenty":-1.068418,"median":-0.206078,"eighty":0.025461,"marketCap":7373963},{"date":"2026-02-06","current":-0.226531,"twenty":-1.057576,"median":-0.206078,"eighty":0.025461,"marketCap":5996958},{"date":"2026-02-13","current":-0.248393,"twenty":-1.017385,"median":-0.206078,"eighty":0.025461,"marketCap":6575699},{"date":"2026-02-20","current":-0.263093,"twenty":-0.999441,"median":-0.206078,"eighty":0.025461,"marketCap":6964853},{"date":"2026-02-27","current":-0.277039,"twenty":-0.979505,"median":-0.206078,"eighty":0.025461,"marketCap":7334050},{"date":"2026-03-06","current":-0.243493,"twenty":-0.958695,"median":-0.206078,"eighty":0.025461,"marketCap":6445981},{"date":"2026-03-13","current":-0.172254,"twenty":-0.948485,"median":-0.205281,"eighty":0.025461,"marketCap":4560083},{"date":"2026-03-20","current":-0.169616,"twenty":-0.923304,"median":-0.205265,"eighty":0.025461,"marketCap":4490235},{"date":"2026-03-27","current":-0.169993,"twenty":-0.89925,"median":-0.203635,"eighty":0.025461,"marketCap":4500213}],"updateTime":1774703984314},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APVO\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2602798893","title":"BRIEF-Aptevo Therapeutics On Jan 8, Enters Equity Purchase Agreement With Ya Ii Pn, Ltd","url":"https://stock-news.laohu8.com/highlight/detail?id=2602798893","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602798893?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:31","pubTimestamp":1767965476,"startTime":"0","endTime":"0","summary":"BRIEF-Aptevo Therapeutics On Jan 8, Enters Equity Purchase Agreement With Ya Ii Pn, LtdJan 9  - Aptevo Therapeutics Inc APVO.O:APTEVO THERAPEUTICS INC - ON JAN 8, ENTERS EQUITY PURCHASE AGREEMENT WITH YA II PN, LTD. - SEC FILINGAPTEVO THERAPEUTICS INC - CAN ISSUE UP TO $60 MILLION OF COMMON STOCK - SEC FILINGSource text: [ID:n0001193125-26-008318]Further company coverage: APVO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3Y91GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2602376918","title":"Aptevo Therapeutics Inc - on Jan 8, Enters Equity Purchase Agreement With Ya Ii Pn, Ltd. - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376918","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376918?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:18","pubTimestamp":1767964703,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3Y91GF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2602376913","title":"Aptevo Therapeutics Inc - Can Issue up to $60 Mln of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376913","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376913?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:18","pubTimestamp":1767964703,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nFWN3Y91GF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2602376346","title":"Aptevo Therapeutics Secures $60 Million Equity Line of Credit from Yorkville Advisors","url":"https://stock-news.laohu8.com/highlight/detail?id=2602376346","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602376346?lang=en_us&edition=fundamental","pubTime":"2026-01-09 21:05","pubTimestamp":1767963921,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. has entered into a $60 million equity line of credit  agreement with Yorkville Advisors Global, LP. This financing facility provides Aptevo with flexible access to capital, allowing the company to raise funds incrementally and at its discretion under market-based conditions. The ELOC, which carries minimal fees and no warrants, is intended to support ongoing clinical development, advance preclinical programs, and fund general corporate purposes. Together with existing cash on hand, the fully leveraged facility is expected to extend Aptevo's funding runway into 2029, enabling the achievement of key clinical and preclinical milestones. The company retains full discretion over the use of the facility and is not required to draw on it.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL787mjc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APVO"],"gpt_icon":0},{"id":"2595753745","title":"Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2595753745","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595753745?lang=en_us&edition=fundamental","pubTime":"2025-12-30 06:06","pubTimestamp":1767045971,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. has announced an amendment to its Certificate of Incorporation to implement a reverse stock split at a ratio of 1-for-18. The reverse split, approved by the company's board, consolidates every 18 shares of issued and outstanding common stock into one share, effective December 29, 2025. Proportionate adjustments will be made to outstanding stock options, restricted stock units, and warrants, as well as to the number of shares reserved under equity compensation plans. No fractional shares will be issued as a result of the split.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDL8ChgjR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APVO"],"gpt_icon":0},{"id":"2594218642","title":"Top Midday Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2594218642","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594218642?lang=en_us&edition=fundamental","pubTime":"2025-12-27 03:31","pubTimestamp":1766777508,"startTime":"0","endTime":"0","summary":"Dermata Therapeutics  said Wednesday it agreed to sell 2.02 million shares, along with related Series C and short-term Series D warrants, in a private placement priced at $2.04 a share, with gross proceeds of as much as $12.4 million.The stock fell 20% as intraday volume topped 617,800 shares, compared with the daily average of 537,661.Aptevo Therapeutics  will implement a 1-for-18 reverse stock split, effective at the start of trading on Tuesday.The shares fell 38% as intraday volume topped 13.6 million, compared with the daily average of 2.09 million.Price: 1.91, Change: -0.47, Percent Change: -19.62","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","DRMA","BK4139","BK4539","APVO"],"gpt_icon":0},{"id":"2594617299","title":"Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2594617299","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2594617299?lang=en_us&edition=fundamental","pubTime":"2025-12-26 21:05","pubTimestamp":1766754314,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. has announced a 1-for-18 reverse stock split of its common stock, effective December 29, 2025. Following the split, every 18 shares of existing common stock will be consolidated into one share. The stock will continue to trade under the symbol \"APVO\" on the Nasdaq Capital Market, with trading on a split-adjusted basis beginning December 30, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via ACCESS Newswire  on December 26, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251226:nNDLbJz56F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APVO"],"gpt_icon":0},{"id":"2590349514","title":"Aptevo Therapeutics Reports Strong Remission Rates and Safety for Mipletamig in Frontline AML Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2590349514","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590349514?lang=en_us&edition=fundamental","pubTime":"2025-12-09 21:05","pubTimestamp":1765285520,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. has announced preliminary results from its ongoing Phase 1b/2 RAINIER clinical study evaluating mipletamig, a CD123 x CD3 bispecific molecule, in combination with azacitidine and venetoclax for newly diagnosed acute myeloid leukemia  patients unfit for intensive chemotherapy. The data, presented on December 8, 2025, at the American Society of Hematology  Annual Meeting, showed that across dose-optimization cohorts 1-3, 100% of patients remained free of cytokine release syndrome. The overall response rate among evaluable patients was 93%, with 87% achieving complete remission or complete remission with incomplete hematologic recovery, and 73% achieving complete remission. Additionally, 60% of MRD-evaluable patients who achieved remission were negative for minimal residual disease. The study is ongoing, with continued patient enrollment at additional dose levels.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligen","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251209:nNDL4HxSrD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APVO"],"gpt_icon":0},{"id":"2583358535","title":"Aptevo Therapeutics Director Grady Grant III Acquires Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583358535","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583358535?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:33","pubTimestamp":1762983215,"startTime":"0","endTime":"0","summary":"Grady Grant III, a director of Aptevo Therapeutics Inc., has reported the acquisition of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL3QbFQN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","APVO","BK4139","BK4583"],"gpt_icon":0},{"id":"2582287188","title":"Aptevo Therapeutics Unveils Preclinical Data for Trispecific Antibody APVO451 in Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2582287188","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582287188?lang=en_us&edition=fundamental","pubTime":"2025-11-10 21:09","pubTimestamp":1762780170,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. has announced the first presentation of preclinical data for its new trispecific antibody candidate, APVO451. The data were presented at the Society for Immunotherapy of Cancer  Annual Meeting on November 8, 2025. APVO451 is designed to address immune suppression in the tumor microenvironment of hard-to-treat solid tumors, including urothelial, breast, and pancreatic cancers. The molecule targets nectin-4 on tumor cells and incorporates Aptevo's proprietary CRIS-7-derived CD3 binding domain to activate T cells, as well as engaging CD40 to restore the function of antigen-presenting cells. The company reported that APVO451 is advancing through ongoing preclinical studies with the goal of supporting future clinical development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL9Bx6PL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","APVO","BK4583","BK4139"],"gpt_icon":0},{"id":"2581196470","title":"Aptevo Therapeutics management to meet virtually with Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2581196470","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581196470?lang=en_us&edition=fundamental","pubTime":"2025-11-07 02:25","pubTimestamp":1762453523,"startTime":"0","endTime":"0","summary":"Virtual Meeting to be held on November 13-14 hosted by Roth Capital. Published first on TheFly – the ultimate source for real-time, market-moving b...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-management-to-meet-virtually-with-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-management-to-meet-virtually-with-roth-capital-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APVO"],"gpt_icon":0},{"id":"2581091177","title":"Aptevo Therapeutics reports Q3 EPS (23c) vs. ($357.86) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2581091177","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581091177?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:15","pubTimestamp":1762438521,"startTime":"0","endTime":"0","summary":"“We continue to make disciplined progress across both our clinical and research programs,” said Marvin White, President and Chief Executive Officer...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-reports-q3-eps-23c-vs-357-86-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-reports-q3-eps-23c-vs-357-86-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APVO"],"gpt_icon":0},{"id":"2581096555","title":"Aptevo Therapeutics Q3 EPS $(2.23) Misses $(2.09) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096555","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581096555?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:37","pubTimestamp":1762436248,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(2.23) per share which missed the analyst consensus estimate of $(2.09) by 6.7 percent. This is a 99.38 percent increase over losses of $(357.86) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48684986/aptevo-therapeutics-q3-eps-2-23-misses-2-09-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APVO"],"gpt_icon":0},{"id":"2581493093","title":"Aptevo Therapeutics reports third-quarter net loss of $7.5 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581493093","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581493093?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:06","pubTimestamp":1762434369,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. reported a net loss of $7.5 million, or $2.23 per share, for the three months ended September 30, 2025, compared to a net loss of $5.1 million, or $357.86 per share, for the same period in 2024. Research and development expenses increased to $4.0 million from $3.1 million, primarily due to higher mipletamig and employee costs, offset by lower costs on ALG.APV-527. General and administrative expenses rose to $3.6 million from $2.1 million, mainly due to higher employee costs. A non-cash dividend of $1.5 million was recorded related to the down round feature of warrants, increasing net loss attributable to common shareholders to $9.0 million for EPS purposes. As of September 30, 2025, cash and cash equivalents totaled $21.1 million, with an additional $4.1 million raised in October, resulting in a proforma cash position of $25.2 million. The company states it has sufficient cash resources to meet projected operating requirements for at least twelve months from th","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL6DpyM5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APVO","BK4583","EBS"],"gpt_icon":0},{"id":"2581093116","title":"Aptevo Therapeutics Q3 Operating Income USD -7.61 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093116","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093116?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:05","pubTimestamp":1762434301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLX4CF10D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APVO","BK4139"],"gpt_icon":0},{"id":"2581093114","title":"Aptevo Therapeutics Q3 EPS USD -2.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2581093114","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581093114?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:05","pubTimestamp":1762434301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nPLX4CF10D:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APVO"],"gpt_icon":0},{"id":"2580219670","title":"Aptevo Therapeutics Inc  expected to post a loss of $2.09 a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580219670","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580219670?lang=en_us&edition=fundamental","pubTime":"2025-11-03 22:06","pubTimestamp":1762178765,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc  expected to post a loss of $2.09 a share - Earnings Preview Aptevo Therapeutics Inc APVO.OQ APVO.O is expected to  show no change in quarterly revenue when it reports  results","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF18T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4139","BK4583","APVO"],"gpt_icon":0},{"id":"2573923624","title":"Aptevo Therapeutics announces interim results for mipletamig in frontline AML from ongoing RAINIER clinical trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2573923624","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573923624?lang=en_us&edition=fundamental","pubTime":"2025-10-08 20:20","pubTimestamp":1759926013,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. has announced its participation in several upcoming scientific and industry conferences in the fourth quarter of 2025, where it will present updates on its clinical programs. Interim results from the ongoing Phase 1b/2 RAINIER trial evaluating mipletamig in frontline combination therapy for the treatment of acute myeloid leukemia  will be presented in a poster session at the American Society of Hematology  2025 Annual Meeting, scheduled for December 6-9, 2025. Additionally, Aptevo's research and development team will present a poster on a novel trispecific therapeutic targeting Nectin-4, CD3, and CD40 at the Society of Immunotherapy in Cancer  2025 Annual Meeting, taking place November 5-9, 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251008:nNDL6dYwzY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APVO","EBS","BK4583"],"gpt_icon":0},{"id":"2572682401","title":"Aptevo Therapeutics Files Initial Beneficial Ownership Statement for Bank of America Corp","url":"https://stock-news.laohu8.com/highlight/detail?id=2572682401","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572682401?lang=en_us&edition=fundamental","pubTime":"2025-10-04 02:00","pubTimestamp":1759514429,"startTime":"0","endTime":"0","summary":"Aptevo Therapeutics Inc. has filed an initial statement of beneficial ownership , identifying Bank of America Corporation as the beneficial owner. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 03, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251003:nNDL2zKmCC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2129689431.USD","LU0106831901.USD","BK4504","LU1506573853.SGD","IE00BBT3K403.USD","IE00BZ1G4Q59.USD","LU0170899867.USD","LU0203347892.USD","BAC","LU0203345920.USD","LU0306807586.USD","LU0314106906.USD","LU0128525689.USD","LU1366192091.USD","LU1880398554.USD","LU0321505868.SGD","LU0477156953.USD","LU0053666078.USD","LU0683600562.USD","BK4139","LU0149725797.USD","LU0787776722.HKD","LU0648000940.SGD","LU0648001328.SGD","LU1883839398.USD","IE00B1BXHZ80.USD","LU1894683348.USD","LU2129689514.USD","BK4534","LU0070302665.USD","IE00B19Z3B42.SGD","BK4588","BK4553","LU0321505439.SGD","LU1074936037.SGD","BK4583","EBS","IE00BLSP4239.USD","BK4559","APVO","LU0130102774.USD","IE00BKVL7J92.USD","LU1201861165.SGD","BK4585","LU1894683264.USD","LU2133065610.SGD","LU1668664300.SGD","LU1280957306.USD","LU1069347547.HKD","LU0971096721.USD"],"gpt_icon":0},{"id":"2572505165","title":"Aptevo Therapeutics files to sell 6.9M shares of common stock for holders","url":"https://stock-news.laohu8.com/highlight/detail?id=2572505165","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572505165?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:35","pubTimestamp":1759350907,"startTime":"0","endTime":"0","summary":"16:33 EDT Aptevo Therapeutics (APVO) files to sell 6.9M shares of common stock for holders Published first on TheFly – the ultimate source for real...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-files-to-sell-6-9m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/aptevo-therapeutics-files-to-sell-6-9m-shares-of-common-stock-for-holders-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APVO"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":40,"code":"91000000","status":"200"}]}}